Literature DB >> 11240474

[Choroidal neovascularization as a complication following laser treatment of central serous chorioretinopathy].

P Simon1, A Glacet-Bernard, M Binaghi, G Coscas, G Soubrane.   

Abstract

We report the case of a 39-year old man who presented with central serous chorioretinopathy. Two months after diagnosis, argon laser photocoagulation was performed. One month later, the patient noticed distortion and a reduction in vision revealing a subretinal neovascularization above the fovea next to the laser scar. The patient underwent surgical extraction of the neovascular membrane and recovered a visual acuity of 20/30. This case report shows a complication of laser treatment of central serous chorioretinopathy and underlines the diagnostic difficulties of this disease and its treatment modalities. The surgical excision, the first reported in this etiology, led to good visual recovery, as is usually observed in young patients operated on for neovascular membrane.

Entities:  

Mesh:

Year:  2001        PMID: 11240474

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  5 in total

1.  Effects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational study.

Authors:  Yildirim Bayezit Sakalar; Ugur Keklikci; Kaan Unlu; Mehmet Fuat Alakus; Ismail Hamdi Kara
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

2.  Selective retina therapy in patients with central serous chorioretinopathy.

Authors:  H Elsner; E Pörksen; C Klatt; A Bunse; D Theisen-Kunde; R Brinkmann; R Birngruber; H Laqua; J Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

3.  Photodynamic therapy rescue for subretinal fluid exacerbation after focal laser treatment in idiopathic central serous chorioretinopathy.

Authors:  Theodore Leng; Steven R Sanislo; Robert L Jack
Journal:  Open Ophthalmol J       Date:  2011-01-18

4.  Subthreshold Continuous Wave Autofluorescence-controlled Laser Treatment of Chronic Central Serous Chorioretinopathy.

Authors:  Hossein Ashraf; Mansooreh Jamshidian; Mohammad Reza Khalili; Mousa Zare; Anis Shamsi
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

5.  Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results.

Authors:  Maximilian Büttner; Benjamin Luger; Katharina Knoll; Amelie Pielen; Wasim Abou Moulig; Bernd Junker; Carsten Framme; Christina Jacobsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-18       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.